Inari Medical, Inc. revised revenue guidance for the year 2023. For the full year 2023, the company is raising revenue guidance to a range of $490 million to $493 million, an increase of $4.5 million at the midpoint from prior guidance range of $482 million to $492 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.96 USD | +1.17% | -5.07% | -27.94% |
May. 23 | Sector Update: Health Care Stocks Lower Thursday Afternoon | MT |
May. 23 | Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.94% | 2.7B | |
-25.87% | 7.29B | |
+5.81% | 6.75B | |
+18.57% | 5.5B | |
-18.64% | 4.75B | |
+18.17% | 4.1B | |
-20.73% | 3.93B | |
+43.13% | 2.31B | |
+1.86% | 2.06B | |
+11.32% | 1.97B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Revises Revenue Guidance for the Year 2023